TearLab acquires AOA’s OcuHub technology platform

Article

TearLab recently closed the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association (AOA).

San Diego, CA-TearLab recently closed the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association (AOA).

As of the close of the transaction, the OcuHub purchased assets and business activities will be operated as a wholly owned subsidiary of TearLab. Barry Barresi, OD, OcuHub’s CEO and former executive director of the AOA, will remain CEO of TearLab’s OcuHub subsidiary.

The net purchase was about $1.4 million.

OcuHub, powered by AT&T and Covisint, facilitates a shared care model with a single sign-on portal, which provides secure connectivity among doctors, patients, institutions, and payers. It is a subscription-based service that is HIPAA compliant.

OcuHub also offers electronic medical records software, image management and storage, practice management tools, and marketing programs.

Recent Videos
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
© 2025 MJH Life Sciences

All rights reserved.